FDA Inspection 1274854 — Joanna Gozdzik, M.D

Joanna Gozdzik, M.D — FEI 3033983173

The FDA completed an inspection of Joanna Gozdzik, M.D on Jun 6, 2025 in Katowice. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI)
End Date
Jun 6, 2025
Fiscal Year
2025
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Katowice (Poland)

Additional Details

Clinical Investigator (CI)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.